Professional Documents
Culture Documents
Dot Blot Protocol
Dot Blot Protocol
Proteins are adhered to a nitrocellulose membrane (via dot blot) or PVDF membrane (via gel
electrophoresis and transfer chamber) and then cut into strips that are used to screen
combinations of serial dilutions of primary to secondary antibodies. For comparable results,
it is important to keep all protocol parameters the same, such as sample type, incubation
times, wash times and temperatures.
1. Prepare the protein sample in the desired buffer. The protein sample should contain
an abundance of the antigen of interest. Usually, the antigen concentration of a
sample is unknown, so a wide range of dilutions may need to be tested.
2. Cut a nitrocellulose membrane into 1cm strips, enough to test the number of
primary and secondary antibody dilutions to be screened. Label the strips of
antibody dilutions with pencil.
o If a PVDF membrane is used, then run the protein sample through gel
electrophoresis and transfer to the PVDF membrane. Do not let the PVDF
membrane dry out. Proceed to step 4.
3. Dot the protein dilutions onto the dry nitrocellulose membrane strips using as little
volume as possible for each dot (1-5 µl) so that sample does not spread across the
membrane. To dot samples greater than 5µl, dot smaller volumes multiple times on
the same spot allowing each dot to absorb and dry for 2-5 minutes. After dotting is
complete, allow the strips to completely dry for 10-15 minutes.
4. Block the membrane by incubating in blocking buffer for 1-2 hours at room
temperature. Use a shaker to ensure even coverage of non-specific sites on the
membranes.
5. Incubate the membrane strips with the appropriate primary antibody dilution in
washing buffer containing 10% volume of blocking buffer for 1 hour on an orbital
shaker. The strips that are receiving the same concentration of primary antibody
may be incubated together in the same bath.
o The typical starting primary antibody dilution is 1:1000, so test a series of
1:250, 1:500, 1:1000, 1:2000 and 1:4000 (0.2 to 5.0 µg/ml).
If there is no recommended dilution then start with 1 µg/ml of
purified antibody.
Negative control samples with no primary or secondary antibodies
should also be included to reveal non-specific cross-reactivity.